HHS Aims To Reduce Prescription Drug Costs Through 3 New Models
The U.S. Department of Health & Human Services announced three models Tuesday that will be tested by the CMS Innovation Center and aim to lower prescription drug costs. The models, which include access to $2 generic drugs, build on the Inflation Reduction Act of 2022.
Information Courtesy By: Marissa Plescia, #HealthcareNews #Healthcare | Feeds
The U.S. Department of Health & Human Services announced three models Tuesday that will be tested by the CMS Innovation Center and aim to lower prescription drug costs. The models, which include access to $2 generic drugs, build on the Inflation Reduction Act of 2022.
Click For More Details
2023-02-16 00:16
Except for the headline, this story has not been edited by Healthcare Central is published from a syndicated feed.